VICTRELIS TRIPLE
VICTRELIS TRIPLE
Discontinued
DIN Number
02371456
Drug Class
Human
Market Date
Aug 16, 2011
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02371456
AIG Number0352956002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AB60 PEGINTERFERON ALFA-2B, COMBINATIONS
Product Specifications
Dosage FormPowder For Solution
,
Capsule
Route of AdministrationOral
,
Subcutaneous
AHFS Classification08:18.32
Health Canada Classification
ACTIVE INGREDIENTS (3)
BOCEPREVIRActive
Strength: 200 MG / CAP
Monograph: BOCEPREVIR
PEGINTERFERON ALFA-2BActive
Strength: 100 MCG / 0.5 ML
Monograph: PEGINTERFERON ALFA-2B
RIBAVIRINActive
Strength: 200 MG / CAP
Monograph: RIBAVIRIN